Vanoxerine, a new drug for terminating atrial fibrillation and flutter

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 3, 2010, Pages 311-319

  Matsumoto, Naomichi ^a   Khrestian, Celeen M ^a   Ryu, Kyungmoo ^a   Lacerda, Antonio E ^a   Brown, Arthur M ^a   Waldo, Albert L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antiarrhythmic drug therapy; Atrial fibrillation (AFL); Atrial flutter (AF); QT interval; Vanoxerine

Indexed keywords

VANOXERINE; ANTIASTHMATIC AGENT; PIPERAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; EPICARDIUM MAPPING; HEART ATRIUM FIBRILLATION; NONHUMAN; PR INTERVAL; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; ANIMAL; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART RATE; PATHOPHYSIOLOGY; RADIATION RESPONSE; TREATMENT OUTCOME;

ANIMALS; ANTI-ASTHMATIC AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DOGS; ELECTROCARDIOGRAPHY; HEART RATE; PIPERAZINES; TREATMENT OUTCOME;

EID: 77649107754     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01622.x     Document Type: Article

References (16)

1. Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG : Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 1992 42 : 383 390.
2. Lacerda AE, Kuryshev YA, Yan G-X, Waldo AL, Brown AM : Vanoxerine: Molecular mechanisms of a new antiarrhythmic drug. J Cardiovasc Electrophysiol DOI :.
3. Sogaard U, Michalow J, Butler B, Lund Laursen A, Ingersen SH, Skrumsager BK, Rafaelsen OJ : A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects. Int Clin Psychopharmacol 1990 5 : 237 251.
4. Page PL, Plumb VJ, Okumura K, Waldo AL : A new animal model of atrial flutter. J Am Coll Cardiol 1986 8 : 872 879.
5. Kumagai K, Khrestian C, Waldo AL : Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model. Insights into the mechanism of its maintenance. Circulation 1997 95 : 511 521.
6. Goldstein RN, Khrestian C, Carlsson L, Waldo AL : AZD7009: A new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. J Cardiovasc Electrophysiol 2004 15 : 1444 1450.
7. Wells JL Jr., Karp RB, Kouchoukos NT, MacLean WA, James TN, Waldo AL : Characterization of atrial fibrillation in man: Studies following open heart surgery. Pacing Clin Electrophysiol 1978 1 : 426 438.
8. Okumura K, Plumb VJ, Page PL, Waldo AL : Atrial activation sequence during atrial flutter in the canine pericarditis model and its effects on the polarity of the flutter wave in the electrocardiogram. J Am Coll Cardiol 1991 17 : 509 518.
9. Shimizu A, Nozaki A, Rudy Y, Waldo AL : Onset of induced atrial flutter in the canine pericarditis model. J Am Coll Cardiol 1991 17 : 1223 1234.
10. Wells JL Jr., MacLean WA, James TN, Waldo AL : Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes. Circulation 1979 60 : 665 673.
11. Ortiz J, Nozaki A, Shimizu A, Khrestian C, Rudy Y, Waldo AL : Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter. Circulation 1994 89 : 2860 2869.
12. Ortiz J, Igarashi M, Gonzalez HX, Laurita K, Rudy Y, Waldo AL : Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model. Circulation 1993 88 : 1866 1877.
13. Matsuo K, Uno K, Khrestian CM, Waldo AL : Conduction left-to-right and right-to-left across the crista terminalis. Am J Physiol Heart Circ Physiol 2001 280 : H1683 H1691.
14. Bui HM, Khrestian CM, Ryu K, Sahadevan J, Waldo AL : Fixed intercaval block in the setting of atrial fibrillation promotes the development of atrial flutter. Heart Rhythm 2008 5 : 1745 1752.
15. Preti A : Vanoxerine National Institute on drug abuse. Curr Opin Investig Drugs 2000 1 : 241 251.
16. Ingwersen SH, Mant TG, Larsen JJ : Food intake increases the relative oral bioavailability of vanoxerine. Br J Clin Pharmacol 1993 35 : 308 310.